111 related articles for article (PubMed ID: 22365834)
1. Effect of an inactivated bluetongue serotype 8 vaccine on semen quality in rams.
Leemans J; Raes M; Saegerman C; Sustronck B; Makoschey B; Kirschvink N
Vet J; 2012 Aug; 193(2):567-9. PubMed ID: 22365834
[TBL] [Abstract][Full Text] [Related]
2. Viral RNA load in semen from bluetongue serotype 8-infected rams: relationship with sperm quality.
Leemans J; Raes M; Vanbinst T; De Clercq K; Saegerman C; Kirschvink N
Vet J; 2012 Jun; 192(3):304-10. PubMed ID: 21802323
[TBL] [Abstract][Full Text] [Related]
3. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
[TBL] [Abstract][Full Text] [Related]
4. Impact of a natural bluetongue serotype 8 infection on semen quality of Belgian rams in 2007.
Kirschvink N; Raes M; Saegerman C
Vet J; 2009 Nov; 182(2):244-51. PubMed ID: 18693049
[TBL] [Abstract][Full Text] [Related]
5. Vaccines against bluetongue in Europe.
Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
[TBL] [Abstract][Full Text] [Related]
6. Transient adverse effects of an attenuated bluetongue virus vaccine on the quality of ram semen.
Bréard E; Pozzi N; Sailleau C; Durand B; Catinot V; Sellem E; Dumont P; Guérin B; Zientara S
Vet Rec; 2007 Mar; 160(13):431-5. PubMed ID: 17400901
[TBL] [Abstract][Full Text] [Related]
7. Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
Steinrigl A; Revilla-Fernández S; Eichinger M; Koefer J; Winter P
Vaccine; 2010 Aug; 28(34):5573-81. PubMed ID: 20600511
[TBL] [Abstract][Full Text] [Related]
8. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
[TBL] [Abstract][Full Text] [Related]
11. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.
Wäckerlin R; Eschbaumer M; König P; Hoffmann B; Beer M
Vaccine; 2010 Jun; 28(27):4348-55. PubMed ID: 20438878
[TBL] [Abstract][Full Text] [Related]
13. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.
Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G
Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907
[TBL] [Abstract][Full Text] [Related]
16. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Vrijenhoek MP; Debyser I; Gregg DA; Dufe DM; Moulin V; Moormann RJ; de Smit AJ
Vaccine; 2012 Jan; 30(3):647-55. PubMed ID: 22107846
[TBL] [Abstract][Full Text] [Related]
17. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
[TBL] [Abstract][Full Text] [Related]
18. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
[TBL] [Abstract][Full Text] [Related]
19. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
